BioSpace News Archive

The $100 million tranche brings the company’s total fundraising efforts this over the past 18 months to $165 million.

Knowing how to spruce up the document can help you be remembered. Here are some ways to set yourself apart with your cover letter!

The data-manipulation scandal with Novartis is widening, undermining investors’ trust in company chief executive officer Vas Narasimhan.

“It’s important to recognize that this problem is there and this problem is persisting over the years,” Kanwal Raghav, author of the study and an oncologist at MD Anderson Cancer Center, told STAT.

CVS Health Corporation (“CVS Health”, NYSE: CVS) announced today the final results of the previously announced cash tender offers (the “Any and All Tender Offers” and each an “Any and All Tender Offer”) for (1) any and all of its 3.125% Senior Notes due 2020 (the “2020 Any and All Notes”) and (2) any and all of its 4.125% Senior Notes due 2021,

The total of 21,969,132 shares that the Company expects to accept for repurchase represents approximately 13.7% of the Company’s total outstanding shares of common stock as of August 16, 2019.

GE Healthcare facility in Chicago to support clinical investigation needs of the C-Scan® System in the U.S.

Vanda Pharmaceuticals Inc. announced that on August 16 2019, it received a Complete Response Letter from the U.S. Food and Drug Administration as part of its ongoing review of Vanda’s supplemental New Drug Application for HETLIOZ® for the treatment of Jet Lag Disorder.

ET-104 Successfully Demonstrated Bioequivalence to Currently Approved Oral Solid Formulation

Mr. Nolet brings more than 38 years of financial leadership experience in the Life Sciences industry.